• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前蛋白转化酶枯草溶菌素9(PCSK9)在介导高脂血症中产生白细胞介素-17的T细胞反应中的关键作用。

A Critical Role of PCSK9 in Mediating IL-17-Producing T Cell Responses in Hyperlipidemia.

作者信息

Kim Young Uk, Kee Patrick, Danila Delia, Teng Ba-Bie

机构信息

Center for Immunology and Autoimmune Diseases, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

出版信息

Immune Netw. 2019 Dec 4;19(6):e41. doi: 10.4110/in.2019.19.e41. eCollection 2019 Dec.

DOI:10.4110/in.2019.19.e41
PMID:31921471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6943168/
Abstract

We previously demonstrated that atherogenic (LDb) double knockout mice lacking both low-density lipoprotein receptor (LDLR) and apolipoprotein B mRNA-editing catalytic polypeptide-1 (Apobec1) had increased serum IL-17 levels, with T cell programming shifted towards Th17 cells. In this study, we assessed the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in T cell programming and atherogenesis. We deleted the gene from LDb mice to generate (LTp) triple knockout mice. Atherosclerosis in the aortic sinus and aorta were quantitated. Lymphoid cells were analyzed by flow cytometry, ELISA and real-time PCR. Despite of dyslipidemia, LTp mice developed barely detectable atherosclerotic lesions. The IL-17, was very low in plasma and barely detectable in the aortic sinus in the LTp mice. In the spleen, the number of CD4CD8 cells and splenocytes were much lower in the LDb mice than LTp mice, whereas, the IL-17-producing cells of γδTCR T cells and effector memory CD4 T cells (CD44CD4) in the spleen were significantly higher in the LDb mice than in the LTp mice. The Rorc mRNA expression levels were elevated in LDb mice compared to LTp mice. When re-stimulated with an anti-CD3 Ab, CD44CD4 T cells from LDb mice secreted more IL-17 than those from LTp mice. T cells from LDb mice (with PCSK9) produce more IL-17 at basal and stimulated conditions when compared with LTp mice (without PCSK9). Despite the dyslipidemic profile and the lack of LDLR, atherogenesis is markedly reduced in LTp mice. These results suggest that PCSK9 is associated with changes in T cell programming that contributes to the development of atherosclerosis.

摘要

我们之前证明,缺乏低密度脂蛋白受体(LDLR)和载脂蛋白B mRNA编辑催化多肽-1(Apobec1)的致动脉粥样硬化(LDb)双敲除小鼠血清白细胞介素-17(IL-17)水平升高,T细胞编程向Th17细胞偏移。在本研究中,我们评估了前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)在T细胞编程和动脉粥样硬化发生中的作用。我们从LDb小鼠中删除该基因以产生(LTp)三敲除小鼠。对主动脉窦和主动脉中的动脉粥样硬化进行定量分析。通过流式细胞术、酶联免疫吸附测定(ELISA)和实时聚合酶链反应(PCR)分析淋巴细胞。尽管存在血脂异常,但LTp小鼠几乎未出现可检测到的动脉粥样硬化病变。LTp小鼠血浆中的IL-17水平非常低,在主动脉窦中几乎检测不到。在脾脏中,LDb小鼠的CD4CD8细胞和脾细胞数量比LTp小鼠少得多,而LDb小鼠脾脏中产生IL-17的γδTCR T细胞和效应记忆CD4 T细胞(CD44CD4)明显高于LTp小鼠。与LTp小鼠相比,LDb小鼠中Rorc mRNA表达水平升高。用抗CD3抗体再次刺激时,来自LDb小鼠的CD44CD4 T细胞比来自LTp小鼠的分泌更多的IL-17。与LTp小鼠(无PCSK9)相比,来自LDb小鼠(有PCSK9)的T细胞在基础和刺激条件下产生更多的IL-17。尽管存在血脂异常且缺乏LDLR,但LTp小鼠的动脉粥样硬化发生明显减少。这些结果表明,PCSK9与T细胞编程的变化有关,这有助于动脉粥样硬化的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/90ebae1ab001/in-19-e41-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/47ab7fccd778/in-19-e41-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/b71bc5b34174/in-19-e41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/41be536d5ce4/in-19-e41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/7b7772c34d75/in-19-e41-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/90ebae1ab001/in-19-e41-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/47ab7fccd778/in-19-e41-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/b71bc5b34174/in-19-e41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/41be536d5ce4/in-19-e41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/7b7772c34d75/in-19-e41-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fbc/6943168/90ebae1ab001/in-19-e41-g005.jpg

相似文献

1
A Critical Role of PCSK9 in Mediating IL-17-Producing T Cell Responses in Hyperlipidemia.前蛋白转化酶枯草溶菌素9(PCSK9)在介导高脂血症中产生白细胞介素-17的T细胞反应中的关键作用。
Immune Netw. 2019 Dec 4;19(6):e41. doi: 10.4110/in.2019.19.e41. eCollection 2019 Dec.
2
PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.PCSK9 缺乏可减少动脉粥样硬化、载脂蛋白 B 分泌和内皮功能障碍。
J Lipid Res. 2018 Feb;59(2):207-223. doi: 10.1194/jlr.M078360. Epub 2017 Nov 27.
3
Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.血浆中非酯化脂肪酸和血小板活化因子乙酰水解酶水平升高与小鼠动脉粥样硬化易感性相关。
Clin Sci (Lond). 2004 Apr;106(4):421-32. doi: 10.1042/CS20030375.
4
Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.脂联素受体的激活调节前蛋白转化酶枯草溶菌素/克新9型的表达并抑制载脂蛋白E缺陷小鼠的病变。
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1290-1300. doi: 10.1161/ATVBAHA.117.309630. Epub 2017 May 25.
5
Local effects of human PCSK9 on the atherosclerotic lesion.人源前蛋白转化酶枯草溶菌素9(PCSK9)对动脉粥样硬化病变的局部影响。
J Pathol. 2016 Jan;238(1):52-62. doi: 10.1002/path.4630. Epub 2015 Nov 13.
6
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.人类前蛋白转化酶枯草溶菌素9通过载脂蛋白E和低密度脂蛋白受体介导的机制促进肝脏脂肪生成和动脉粥样硬化发展。
Cardiovasc Res. 2016 May 15;110(2):268-78. doi: 10.1093/cvr/cvw053. Epub 2016 Mar 15.
7
Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9):肝细胞特异性低密度脂蛋白受体降解及在小鼠肝脏再生中的关键作用。
Hepatology. 2008 Aug;48(2):646-54. doi: 10.1002/hep.22354.
8
β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.β-雌二醇导致人肝HuH7细胞中低密度脂蛋白受体水平在一种枯草杆菌蛋白酶/kexin 9型前蛋白转化酶依赖的情况下升高。
FEBS J. 2015 Jul;282(14):2682-96. doi: 10.1111/febs.13309. Epub 2015 May 18.
9
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.培养的平滑肌细胞分泌的前蛋白转化酶枯草溶菌素 9(PCSK9)降低巨噬细胞 LDLR 水平。
Atherosclerosis. 2012 Feb;220(2):381-6. doi: 10.1016/j.atherosclerosis.2011.11.026. Epub 2011 Nov 25.
10
Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia.在家族性高胆固醇血症小鼠模型中,抗白细胞介素-1β单克隆抗体减轻血管钙化
Angiology. 2016 Feb;67(2):157-67. doi: 10.1177/0003319715583205. Epub 2015 Apr 22.

引用本文的文献

1
Lipids, lipid-lowering drugs and the risk of herpes zoster: a Mendelian randomization study.脂质、降脂药物与带状疱疹风险:一项孟德尔随机化研究
Arch Dermatol Res. 2025 Jan 4;317(1):166. doi: 10.1007/s00403-024-03600-1.
2
PCSK9 in T-cell function and the immune response.前蛋白转化酶枯草溶菌素9在T细胞功能和免疫反应中的作用
Biomark Res. 2024 Dec 31;12(1):163. doi: 10.1186/s40364-024-00712-8.
3
Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization.通过人类血浆蛋白质组学和孟德尔随机化综合分析揭示银屑病的新型蛋白质生物标志物

本文引用的文献

1
Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system.利用基于纳米脂质体的疫苗传递系统长效生成抗 PCSK9 抗体。
Atherosclerosis. 2019 Apr;283:69-78. doi: 10.1016/j.atherosclerosis.2019.02.001. Epub 2019 Feb 14.
2
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.调节性 T 细胞促进炎症消退期巨噬细胞的胞葬作用。
Immunity. 2018 Oct 16;49(4):666-677.e6. doi: 10.1016/j.immuni.2018.07.015. Epub 2018 Oct 2.
3
Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A.
Psoriasis (Auckl). 2024 Dec 7;14:179-193. doi: 10.2147/PTT.S492205. eCollection 2024.
4
Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations.肝外组织中前蛋白转化酶枯草杆菌蛋白酶/kexin 9型缺乏症:新出现的考量因素
Front Pharmacol. 2024 Jul 30;15:1413123. doi: 10.3389/fphar.2024.1413123. eCollection 2024.
5
Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study.脂质和降脂药物靶点基因与特应性皮炎的遗传关联:药物靶点孟德尔随机化研究。
Sci Rep. 2024 Aug 5;14(1):18097. doi: 10.1038/s41598-024-69180-2.
6
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis.单细胞转录组分析揭示了免疫细胞对检查点抑制剂诱导的结肠炎上皮屏障功能障碍的不同作用。
Nat Med. 2024 May;30(5):1349-1362. doi: 10.1038/s41591-024-02895-x. Epub 2024 May 9.
7
Genetically proxied PCSK9 inhibition is associated with reduced psoriatic arthritis risk.遗传相关性 PCSK9 抑制与降低银屑病关节炎风险相关。
Inflamm Res. 2024 Mar;73(3):475-484. doi: 10.1007/s00011-024-01850-3. Epub 2024 Feb 11.
8
Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review.前蛋白转化酶枯草溶菌素9(PCSK9)抑制在新型冠状病毒肺炎(SARS-CoV-2)炎症阶段的作用:最新综述
Ann Med Surg (Lond). 2024 Jan 3;86(2):899-908. doi: 10.1097/MS9.0000000000001601. eCollection 2024 Feb.
9
Interorgan communication with the liver: novel mechanisms and therapeutic targets.器官间与肝脏的通讯:新机制和治疗靶点。
Front Immunol. 2023 Dec 12;14:1314123. doi: 10.3389/fimmu.2023.1314123. eCollection 2023.
10
The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis.患有冠状动脉粥样硬化男性的前蛋白转化酶枯草溶菌素9-脂蛋白(a)复合物浓度及血液单核细胞水平
J Pers Med. 2023 Jun 29;13(7):1077. doi: 10.3390/jpm13071077.
肾功能降低时加重的动脉粥样硬化和血管炎症依赖于白细胞介素-17受体A,且通过抑制白细胞介素-17A可使其恢复正常。
JACC Basic Transl Sci. 2018 Jan 10;3(1):54-66. doi: 10.1016/j.jacbts.2017.08.005. eCollection 2018 Feb.
4
Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27.致动脉粥样硬化性血脂异常通过 IL-27 促进自身免疫性滤泡辅助性 T 细胞反应。
Nat Immunol. 2018 Jun;19(6):583-593. doi: 10.1038/s41590-018-0102-6. Epub 2018 Apr 30.
5
Hypercholesterolemia induces T cell expansion in humanized immune mice.高胆固醇血症可诱导人源化免疫小鼠 T 细胞扩增。
J Clin Invest. 2018 Jun 1;128(6):2370-2375. doi: 10.1172/JCI97785. Epub 2018 Apr 30.
6
PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque.前蛋白转化酶枯草溶菌素9(PCSK9)在氧化型低密度脂蛋白诱导的树突状细胞成熟以及人血液和动脉粥样硬化斑块中T细胞的激活过程中发挥着新的免疫作用。
J Intern Med. 2018 Apr 4. doi: 10.1111/joim.12758.
7
Regulatory CD4 T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein B.调节性 CD4 T 细胞识别载脂蛋白 B 的主要组织相容性复合体 II 分子限制性肽表位。
Circulation. 2018 Sep 11;138(11):1130-1143. doi: 10.1161/CIRCULATIONAHA.117.031420.
8
Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis.载脂蛋白 AI 可预防动脉粥样硬化中调节性滤泡辅助 T 细胞的转换。
Nat Commun. 2018 Mar 15;9(1):1095. doi: 10.1038/s41467-018-03493-5.
9
PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions.PCSK9 抑制改变了血浆和脂蛋白部分的脂质组。
Atherosclerosis. 2018 Feb;269:159-165. doi: 10.1016/j.atherosclerosis.2018.01.004. Epub 2018 Jan 12.
10
PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.PCSK9 缺乏可减少动脉粥样硬化、载脂蛋白 B 分泌和内皮功能障碍。
J Lipid Res. 2018 Feb;59(2):207-223. doi: 10.1194/jlr.M078360. Epub 2017 Nov 27.